Ovarian cancer resistance to PARPi and platinum-containing chemotherapy

por Summey, Rebekah, Uyar, Denise
Publicado 2022

Challenges of Genomic Testing for Hereditary Breast and Ovarian Cancers

por McAlarnen, Lindsey, Stearns, Kristen, Uyar, Denise
Publicado 2021

A prospective pilot study on the incidence of post-operative lymphedema in women with endometrial cancer

por Hopp, Elizabeth E., Osborne, Janet L., Schneider, Deborah K., Bojar, Claudia J., Uyar, Denise S.
Publicado 2015

A case series of triplet anti-hormonal therapy in androgen receptor-positive recurrent adult ovarian granulosa cell tumor()

por Summey, Rebekah M., Rader, Janet S., Moh, Michelle, Bradley, William, Uyar, Denise, Bishop, Erin, McAlarnen, Lindsey, Hopp, Elizabeth
Publicado 2022

Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance

por Parashar, Deepak, Geethadevi, Anjali, Mittal, Sonam, McAlarnen, Lindsey A., George, Jasmine, Kadamberi, Ishaque P., Gupta, Prachi, Uyar, Denise S., Hopp, Elizabeth E., Drendel, Holli, Bishop, Erin A., Bradley, William H., Bone, Kathleen M., Rader, Janet S., Pradeep, Sunila, Chaluvally-Raghavan, Pradeep
Publicado 2022

Correction: Parashar et al. Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance. Cancers 2022, 14, 958

por Parashar, Deepak, Geethadevi, Anjali, Mittal, Sonam, McAlarnen, Lindsey A., George, Jasmine, Kadamberi, Ishaque P., Gupta, Prachi, Uyar, Denise S., Hopp, Elizabeth E., Drendel, Holli, Bishop, Erin A., Bradley, William H., Bone, Kathleen M., Rader, Janet S., Pradeep, Sunila, Chaluvally-Raghavan, Pradeep
Publicado 2022